28 June 2022>: Clinical Research
Impact of a Rehabilitation Program on the Change in Components of Body Mass of the Upper and Lower Limbs in People After Ischemic Stroke
Grzegorz Przysada 1ACDF , Justyna Leszczak 2ABEF* , Joanna Baran 2CDE , Andżelina Wolan-Nieroda 2BDF , Bogumiła Pniak 3CDE , Viliam Knap 4BDF , Mariusz Drużbicki 2ADF , Agnieszka Guzik 2ADEDOI: 10.12659/MSM.936397
Med Sci Monit 2022; 28:e936397
Table 7 The effect of rehabilitation on the amount of fat at 7 to 12 and >12 months after stroke.
Time after stroke | Side of paresis | Exam | N | Mean median* | SDQ1–Q3* | p | Mean median* | SDQ1–Q3* | p | Mean median* | SDQ1–Q3* | p | Mean median* | SDQ1–Q3* | p | Mean median* | SDQ1–Q3* | p |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
FAT | FAT right lower limb | FAT left lower limb | FAT right arm | FAT left arm | ||||||||||||||
7–12 months | Left | Exam I | 8 | 27.21 | 10.18 | 0.716*** | 17.97 | 9.96 | 0.704*** | 13.18* | 7.35–22.08* | 0.028** | 12.16 | 7.20 | 0.387*** | 13.36 | 7.15 | 0.877*** |
Exam II | 8 | 25.03 | 9.87 | 15.97 | 9.12 | 14.27* | 9.31–22.73* | 12.39 | 7.41 | 13.39 | 7.00 | |||||||
Right | Exam I | 7 | 22.75 | 4.86 | 0.625*** | 19.34 | 4.57 | 0.027*** | 14.04 | 3.85 | 0.456*** | 11.19 | 2.87 | 0.023*** | 11.60 | 2.51 | 0.033*** | |
Exam II | 7 | 21.78 | 1.84 | 13.86 | 3.85 | 13.81 | 3.73 | 10.08 | 2.09 | 10.59 | 1.84 | |||||||
7–12 months | Left | Exam II | 8 | 25.03 | 9.87 | 0.563*** | 15.97 | 9.12 | 0.999*** | 16.24 | 9.54 | 0.945*** | 12.39 | 7.41 | 0.678*** | 13.39 | 7.00 | 0.848*** |
Exam III | 8 | 25.48 | 9.42 | 15.98 | 6.90 | 16.40 | 6.91 | 11.34 | 4.90 | 12.91 | 4.86 | |||||||
Right | Exam II | 7 | 21.78 | 1.84 | 0.826*** | 13.86 | 3.85 | 0.312*** | 13.81 | 3.73 | 0.472*** | 10.08 | 2.09 | 0.197*** | 10.59 | 1.84 | 0.295*** | |
Exam III | 7 | 21.66 | 2.49 | 16.31 | 5.84 | 15.76 | 5.55 | 13.55 | 6.12 | 13.72 | 7.09 | |||||||
>12 months | Left | Exam I | 18 | 27.63 | 7.53 | 0.747*** | 20.40 | 7.70 | 0.509*** | 18.91* | 12.59–24.38* | 0.307** | 14.76 | 6.14 | 0.680*** | 16.46 | 7.00 | 0.096*** |
Exam II | 18 | 26.83 | 5.19 | 18.68 | 6.49 | 18.72* | 13.09–24.52* | 14.65 | 5.90 | 16.02 | 6.60 | |||||||
Right | Exam I | 27 | 25.26 | 7.59 | 0.429*** | 16.99 | 8.29 | 0.411*** | 18.64* | 12.69–25.95* | 0.493** | 14.04* | 11.43–22.06* | 0.289** | 15.00* | 10.91–22.95* | 0.446** | |
Exam II | 27 | 26.92 | 7.08 | 18.88 | 7.80 | 17.48* | 12.44–23.65* | 14.29* | 11.01–20.90* | 16.04* | 10.19–22.06* | |||||||
>12 months | Left | Exam II | 18 | 26.83 | 5.19 | 0.779*** | 18.68 | 6.49 | 0.042*** | 19.02 | 6.18 | 0.063*** | 14.65 | 5.90 | 0.167*** | 16.02 | 6.60 | 0.357*** |
Exam III | 18 | 26.70 | 6.01 | 21.90 | 7.64 | 21.80 | 7.51 | 17.61 | 6.70 | 17.94 | 7.32 | |||||||
Right | Exam II | 27 | 26.92 | 7.08 | 0.190*** | 18.88 | 7.80 | 0.712*** | 18.35 | 7.66 | 0.667*** | 16.42 | 6.90 | 0.860*** | 16.48 | 7.50 | 0.849*** | |
Exam III | 27 | 27.19 | 7.16 | 19.69 | 8.16 | 19.32 | 8.20 | 16.07 | 7.16 | 16.06 | 7.88 | |||||||
* Median (Q1–Q3); ** Wilcoxon test; *** T-test. |